Application Nr Approved Date Route Status External Links
BLA022458 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Elelyso Is Indicated For The Treatment Of Patients With A Confirmed Diagnosis Of Type 1 Gaucher Disease. Elelyso Is A Hydrolytic Lysosomal Glucocerebroside-Specific Enzyme Indicated For The Treatment Of Patients With A Confirmed Diagnosis Of Type 1 Gaucher Disease ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Taliglucerase Alfa

Comments